These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 38331818

  • 21. Prediction of treatment response in lupus nephritis using density of tubulointerstitial macrophage infiltration.
    Wang J, Lou W, Zhu M, Tu Y, Chen D, Qiu D, Xu F, Liang D, Cheng Z, Zhang H.
    Front Immunol; 2024; 15():1321507. PubMed ID: 38415246
    [Abstract] [Full Text] [Related]

  • 22. Clinical and histological features of lupus nephritis in Japan: A cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR).
    Hiromura K, Ikeuchi H, Kayakabe K, Sugiyama H, Nagata M, Sato H, Yokoyama H, Nojima Y.
    Nephrology (Carlton); 2017 Nov; 22(11):885-891. PubMed ID: 27461874
    [Abstract] [Full Text] [Related]

  • 23. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2005 Nov; 56(3):115-20. PubMed ID: 16334978
    [Abstract] [Full Text] [Related]

  • 24. Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis.
    Dias CB, Malafronte P, Lee J, Resende A, Jorge L, Pinheiro CC, Malheiros D, Woronik V.
    J Nephrol; 2017 Feb; 30(1):87-94. PubMed ID: 26621103
    [Abstract] [Full Text] [Related]

  • 25. Relation of peritubular capillary features to class of lupus nephritis.
    Anutrakulchai S, Titipungul T, Pattay T, Mesung P, Puapairoj A, Sirivongs D, Pongsakul C, Futrakul P, Thinkhamrop B, Johnson RJ.
    BMC Nephrol; 2016 Nov 09; 17(1):169. PubMed ID: 27829387
    [Abstract] [Full Text] [Related]

  • 26. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
    Bertolo M, Baumgart S, Durek P, Peddinghaus A, Mei H, Rose T, Enghard P, Grützkau A.
    Front Immunol; 2020 Nov 09; 11():256. PubMed ID: 32265898
    [Abstract] [Full Text] [Related]

  • 27. Clinico-histomorphologic Characteristics of Lupus Nephritis, Experience at a Center at Dhaka.
    Islam SMJ, Rahman AKMM, Yasmin S, Giti S.
    Saudi J Kidney Dis Transpl; 2021 Nov 09; 32(6):1754-1763. PubMed ID: 35946290
    [Abstract] [Full Text] [Related]

  • 28. S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis.
    Tian J, Chang S, Wang J, Chen J, Xu H, Huang T, Wang J, Kang J, Fan W, Wang Y.
    Mol Immunol; 2023 Aug 09; 160():55-66. PubMed ID: 37379683
    [Abstract] [Full Text] [Related]

  • 29. The Role of New 3D Pathology and Lymphocyte Expression of Interstitial Inflammation in Pediatric-Onset Lupus Nephritis.
    Huang YC, Hsu YC, Chen JP, Fu LS.
    Int J Mol Sci; 2023 Feb 09; 24(4):. PubMed ID: 36834923
    [Abstract] [Full Text] [Related]

  • 30. Association of intrarenal B-cell infiltrates with clinical outcome in lupus nephritis: a study of 192 cases.
    Shen Y, Sun CY, Wu FX, Chen Y, Dai M, Yan YC, Yang CD.
    Clin Dev Immunol; 2012 Feb 09; 2012():967584. PubMed ID: 22792121
    [Abstract] [Full Text] [Related]

  • 31. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
    Sun J, Guo S, Niu F, Liu D, Zhuang Y.
    Mol Med Rep; 2020 Dec 09; 22(6):5436-5443. PubMed ID: 33173997
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J, Aydin S, Cosyns JP, Depresseux G, Jadoul M, Houssiau FA.
    Lupus; 2014 Feb 09; 23(2):159-65. PubMed ID: 24300780
    [Abstract] [Full Text] [Related]

  • 37. Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands+ Macrophages via Activating IL-4/STAT6/PD-L2 Signaling.
    Liang CL, Jiang H, Feng W, Liu H, Han L, Chen Y, Zhang Q, Zheng F, Lu CJ, Dai Z.
    Front Immunol; 2021 Feb 09; 12():683249. PubMed ID: 34290705
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis.
    Gonzalo E, Toldos O, Martínez-Vidal MP, Ordoñez MC, Santiago B, Fernández-Nebro A, Loza E, García I, León M, Pablos JL, Galindo M.
    Arthritis Res Ther; 2012 May 28; 14(3):R126. PubMed ID: 22640796
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.